PMC:7594251 / 26382-26647 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T241","span":{"begin":81,"end":83},"obj":"Chemical"},{"id":"T242","span":{"begin":102,"end":104},"obj":"Chemical"},{"id":"T243","span":{"begin":131,"end":133},"obj":"Chemical"}],"attributes":[{"id":"A241","pred":"chebi_id","subj":"T241","obj":"http://purl.obolibrary.org/obo/CHEBI_73645"},{"id":"A242","pred":"chebi_id","subj":"T242","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A243","pred":"chebi_id","subj":"T243","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"}],"text":" results from the computed tomography: complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD). After comparing NMR results prior to the treatment with the outcome of chemotherapy, the researchers observed lower baseline leve"}

{"project":"LitCovid-PubTator","denotations":[{"id":"366","span":{"begin":102,"end":104},"obj":"Disease"},{"id":"367","span":{"begin":110,"end":129},"obj":"Disease"},{"id":"368","span":{"begin":131,"end":133},"obj":"Disease"}],"attributes":[{"id":"A366","pred":"tao:has_database_id","subj":"366","obj":"MESH:D029461"},{"id":"A367","pred":"tao:has_database_id","subj":"367","obj":"MESH:D018450"},{"id":"A368","pred":"tao:has_database_id","subj":"368","obj":"MESH:D010300"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" results from the computed tomography: complete response (CR), partial response (PR), stable disease (SD), or progressive disease (PD). After comparing NMR results prior to the treatment with the outcome of chemotherapy, the researchers observed lower baseline leve"}